HRA Pharma
Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, MI, within Michigan State University's Grand Rapids Innovation Park.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Ella | Ulipristal | 2010-08-13 | 2028-2030 | |
| Ketoconazole | Ketoconazole | 2014-11-18 | ||
| Levonorgestrel | Levonorgestrel | 2018-07-03 | 2024-2040 | |
| Lysodren | Mitotane | 1982-01-01 | ||
| Metopirone | Metyrapone | 1982-01-01 | — | |
| Opill | Norgestrel | 1982-01-01 | ||
| Ellaone | Ulipristal | 2009-05-15 | 2028-2030 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use